R. Balfour Sartor

Aug 14, 2024 | cell.com | R. Balfour Sartor

• None Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes. :• None Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. :• None The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease.

Mar 16, 2024 | networthynews.com | R. Balfour Sartor

By R. Balfour Sartor, MD., as informed to Stacia FriedmanMy Crohn’s illness signs began in 6th grade when my stomach discomfort was misdiagnosed as appendicitis. Inflammatory bowel illness, that include Crohn’s illness and ulcerative colitis, are often misdiagnosed. Clients typically error IBD signs– diarrhea, stomach discomfort, weight-loss– for a GI bug. Instead of looking for medical attention, they self-medicate with non-prescription solutions such as Pepto Bismol, probiotics, and Imodium.

Mar 15, 2024 | webmd.com | R. Balfour Sartor |Melinda Ratini

By R. Balfour Sartor, MD., as told to Stacia FriedmanMy Crohn’s disease symptoms started in sixth grade when my abdominal pain was misdiagnosed as appendicitis. Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, are frequently misdiagnosed. Patients often mistake IBD symptoms -- diarrhea, abdominal pain, weight loss -- for a GI bug. Rather than seeking medical attention, they self-medicate with over-the-counter remedies such as Pepto Bismol, probiotics, and Imodium.

Mar 15, 2024 | beatlyzer.com | R. Balfour Sartor

I person been conducting Crohn’s illness and ulcerative colitis investigation since 1979. It’s been a 40-plus-year odyssey exploring nan aforesaid theory. My existent investigation seeks to place which gut germs are nan superior activators of nan overly fierce immune consequence and which germs tin suppress these activities. In a normal host, these fierce germs are balanced by protective bacteria that don’t induce inflammation. That protection is not provided successful Crohn’s and IBD patients.

May 18, 2023 | nature.com | Muyiwa Awoniyi |Ajay Gulati |Stephanie Montgomery |Steven Singer |R. Balfour Sartor |Jonathan Swann

This study involves human participants. It includes the use of archived deidentified data collected in the MAL-ED study.